Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV InfectionPHARMACEUTICALSIF4.82022-03-262OAAI
Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjectsINFECTIONIF3.62019-06-107PREAI
Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatmentAIDSIF3.12019-03-016PREAI
Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort CollaborationJOURNAL OF CLINICAL MEDICINEIF2.92018-10-055OAAI
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in ItalyBMC PUBLIC HEALTHIF3.62018-07-1321OAAI
IL-18 and Stem Cell Factor affect hematopoietic progenitor cells in HIV-infected patients treated during primary HIV infectionCYTOKINEIF3.72018-03-019PREAI
Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal siteBMC INFECTIOUS DISEASESIF32018-01-0823OAAI
Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real worldJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62017-11-022OAAI
In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antiviralsJOURNAL OF HEPATOLOGYIF332017-08-0115PREAI
Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literatureBMC INFECTIOUS DISEASESIF32017-03-0123OAAI
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected PatientsANNALS OF INTERNAL MEDICINEIF15.22017-01-0341PREAI
Lower proportion of sustained virologic response and higher residual HCV viremia at the end of direct-acting antivirals treatment in HIV/HCV co-infected as compared with HCV mono-infected patients: meaning and correlatesJOURNAL OF HEPATOLOGYIF332017-01-011PREAI
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimenJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62016-12-2010OAAI
The Different Roles of Interleukin 7 and Interleukin 18 in Affecting Lymphoid Hematopoietic Progenitor Cells and CD4 Homeostasis in Naive Primary and Chronic HIV-Infected PatientsCLINICAL INFECTIOUS DISEASESIF7.32016-09-233OAAI
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational studyBMC INFECTIOUS DISEASESIF32016-08-116OAAI
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral TherapyJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552016-07-12752OAAI
Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1AIDSIF3.12015-11-2816PRE
An anal cancer screening program for MSM in Italy: Prevalence of multiple HPV types and vaccine-targeted infectionsJOURNAL OF CLINICAL VIROLOGYIF3.42015-11-0116PREAI
Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level ViremiaJOURNAL OF CLINICAL MICROBIOLOGYIF5.42015-09-015OAAI
Bone marrow CD34+progenitor cells may harbour HIV-DNA even in successfully treated patientsCLINICAL MICROBIOLOGY AND INFECTIONIF8.52015-03-0112OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向